Multimodal Model Predicts Recurrence

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Gastric Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

Multimodal AI-driven predictive model

This intervention involves a multimodal artificial intelligence (AI) model that integrates clinical data, imaging results, and pathology findings to predict the risk of postoperative recurrence in patients with locally advanced gastric cancer. Unlike traditional methods that may rely on single data sources, this AI-driven model synthesizes multiple types of patient information, offering a comprehensive and personalized prediction of recurrence risk. This approach aims to improve accuracy in identifying high-risk patients, allowing for more tailored follow-up and treatment planning to enhance patient outcomes.

Trial Locations (1)

050011

the Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Qun Zhao

OTHER

NCT06690268 - Multimodal Model Predicts Recurrence | Biotech Hunter | Biotech Hunter